维普期刊资源整合服务平台（V6.5）

214篇 您的检索式：期刊名="Proc Am Assoc Cancer"

选中清除导出查看参考文献查看引证文献引用追踪共11页首页上一页第1页下一页末页 /11 跳转

	题名	作者	年代	出处	被引量
1	In vitro combination effect of docetaxel (RP56976) with vinca alkaloids on cancer cell- lines显示文摘	Hino H Kobayashi K Hayashihara K	1995	Proc Am Assoc Cancer Res1995，36，：	1
2	IgM antibodies to ganglio-side GM3 and GD3 induced by active immunization correlated withsurvival in melanoma patients显示文摘	Takahashi T Chang C Morton DL	1995	Proc Am Assoc Cancer Res1995，36，：	1
3	MRP3,a new multidrug teansporter显示文摘	Koll M Van der Linden M de Hass M	1999	Proc Am Assoc Cancer Res1999，40，：	1
4	Characterization of potency and activity of the VEGF/PDGF recptor tyrosine Kinase inhibitor AG013736 显示文摘	HU-LOWE D HALLIN M FEELEY R	2002	Proc Am Assoc Cancer Res2002，43，：	1
5	Antibody-dependent cell mediated cytotoxicity in breast cancer patients in phase Ⅲ clinical trials of a humanized anti-HER2 antibody显示文摘	Pegram MD Baly D Wirth C	1997	Proc Am Assoc Cancer Res1997，38，：	1
6	Colon cacer screening by a new test:a prospective study of asymptomatic population显示文摘	Samoto K Muratani M Ogawa J	1993	Proc AM ASSOC Cancer Res1993，32，：	1
7	Prospective randomized trial of thymosin α1 immune reconstitution in patients with advanced head and neck squamous carcinoma:5 year results显示文摘	Folf G	1989	Proc Am Assoc Cancer Res1989，30，5：	1
8	Effect of epidermal growth factor receptor tyrosine kinase inhibitor PD 183805 on vascular endothelial growth factor secretion from several tumor models显示文摘	Driscoll D Steinkampf R Patmore S	1999	Proc Am Assoc Cancer Res1999，40，：	1
9	Tumor EGFR membrane staining is not clinically relevant for predicting response in patients receiving gefitinib('Iressa',ZD1839)monotherapy for pretreated advanced non-small-cell lung cancer:IDEAL 1 and 2显示文摘	Bailey LR Kris M Wolf M	2003	Proc Am Assoc Cancer Res2003，44，：	1
10	Cellular up-take and efflux of docetaxel (Taxotere) and paclitaxel ( Taxol in P388 cell line显示文摘	RIOU J F PETITGENET O COMBEAU C	1994	Proc Am Assoc Cancer Res1994，35，：	1
11	MRP3-polymorphisms influencethe response to platinum-based chemotherapy in non-small cell lungcancer(NSCLC)patients显示文摘	Risch A Dally H Müller P	2005	Proc Am Assoc Cancer Res2005，46，：	1
12	L-OHPliplatin and cisplatin in combination with 5-Fu specific thymidilate synthase inhibitors(AG337,ZD1694),and topoisomerase I inhibitor (SN38,CPT-11) in human colonic,ovarian,and breast cancer显示文摘	Raymond E Djeloul S Buquet-Fagot C	1996	Proc Am Assoc Cancer Res1996，37，：	1
13	Toxicity and pharmacokinetics of 17 - allylaminogeldanamycin ( 17 - AAG, NSC-330507)in dogs显示文摘	Noker P E Thompson R B Smith A C	1999	Proc Am Assoc Cancer Res1999，40，：	1
14	Enhancement of gap junctional communicaton of carotenoids correlates with inhibition of neoplastic transformation显示文摘	Zhang L X	1991	Proc Am Assoc Cancer Res1991，，32：	1
15	The novel oncogene CSSCCRO induces extracellular matrix invasion by matrix metalloproteinase-2 expression显示文摘	O-charoenrat P Reddy P Rusch V	2002	Proc Am Assoc Cancer Res2002，43，：	1
16	Comparison of geldanarnycin ( NSC- 122750 ) and 17 - allyaminogeldanamycin (NSC-330507) toxicity in rats显示文摘	Page J Heath J Fulton R	1997	Proc Am Assoc Cancer Res1997，38，：	1
17	Overexpression of vascular endothelial growth factor (VEGF) in MCF -7 breast carcinoma cells facilitates growth in tamoxifen2 treated nude mice and tumor cell dissemination显示文摘	Bullocks J Zhang L Ding IYF	1997	Proc Am Assoc Cancer Res1997，38，：	1
18	The effect of antibody to vas- cular endothelial growth factor and cisplatin on the growth of lung tumors in nude mice显示文摘	Kabbinavar FF Wong JT Ayala RE	1995	Proc Am Assoc Cancer Res1995，36，：	1
19	Tumor necrosis factor as endogenous tumor promoter显示文摘	Fujiki H Komori A Yatsunami J	1993	Proc Am Assoc Cancer Res1993，34，1：	1
20	Stable transfection of human prostate cancer cell line PC-3 with prostate specific antigen induces apoptosis both in-vivo and in-vitro显示文摘	Balbay MD Juang P llansa N	1999	Proc Am Assoc Cancer Res1999，40，：	1

返回顶部每页显示：

共11页首页上一页第1页下一页末页 /11 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示